Literature DB >> 10773570

Twenty years experience with pediatric pacing: epicardial and transvenous stimulation.

J S Sachweh1, J F Vazquez-Jimenez, F A Schöndube, S H Daebritz, H Dörge, E G Mühler, B J Messmer.   

Abstract

OBJECTIVE: Permanent cardiac pacing in children and adolescents is rare and often occurs by means of epicardial pacing. Based on two decades of experience, operative and postoperative data of patients with epicardial and transvenous pacing were analyzed retrospectively.
METHODS: Between October 1979 and December 1998, 71 patients (mean age, 5.3+/-4.2, range, 1 day-16.2 years; mean body weight, 18+/-12; range, 8-56 kg) underwent permanent pacemaker implantation. Indications were sinus node dysfunction and atrio-ventricular block following surgery for congenital heart disease (69%), or congenital atrioventricular block (31%). Pacing was purely atrial (1.4%), purely ventricular (73%), ventricular with atrial synchronization (5. 6%), or atrioventricular synchronized (20%). Epicardial pacing was established in 49 (69%), transvenous in 22 (31%) patients. Follow-up was 3.4+/-3.8 years (epicardial) and 3.0+/-4.0 years (transvenous).
RESULTS: Epicardial leads were implanted in younger patients (mean age: 4.5 vs. 7.0 years, P<0.05) and preferably after surgery induced atrioventricular block (78 vs. 46%, P<0.05). The youngest patient with transvenous pacing was 1.3 years old (weight, 8.5 kg). At implantation epicardial ventricular stimulation threshold at 1.0 ms was 1.07+/-0.46 vs. 0.53+/-0.31 V (transvenous) (P<0.05). The age-adjusted rate of lead-related reoperations was significantly higher in patients with epicardial leads (P<0.05), mainly due to increasing chronic stimulation thresholds resulting in early battery depletion. In three patients who received steroid-eluting epicardial leads initial low thresholds persisted after five month to one years. In two patients with recurrent epicardial threshold increase, steroid-eluting epicardial leads led to good acute and chronic thresholds after nine to 15 month. Two post-operative death (2.8%) were probably due to a dysfunction of the (epicardial) pacing system.
CONCLUSIONS: Transvenous pacing in the pediatric population is associated with a lower acute stimulation threshold and a lower rate of lead-related complications. If epicardial pacing is necessary (e. g. small body weight, special intracardiac anatomy (e.g. Fontan), impossible access to superior caval vein), steroid-eluting leads may be considered.

Entities:  

Mesh:

Year:  2000        PMID: 10773570     DOI: 10.1016/s1010-7940(00)00364-x

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  28 in total

1.  Special problems of pacing in children.

Authors:  Herwig Antretter; Joshua Colvin; Ulli Schweigmann; Herbert Hangler; Daniel Hofer; Karin Dunst; Josef Margreiter; Guenther Laufer
Journal:  Indian Pacing Electrophysiol J       Date:  2003-01-01

2.  Durability of repaired pacemaker leads in the pediatric population.

Authors:  Sarah Chambers; Alex Rusanov; Henry M Spotnitz; Eric S Silver; Leonardo Liberman
Journal:  J Interv Card Electrophysiol       Date:  2011-02-16       Impact factor: 1.900

3.  Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict.

Authors:  M C Post; W Budts; A Van de Bruaene; R Willems; B Meyns; F Rega; M Gewillig
Journal:  Neth Heart J       Date:  2011-08       Impact factor: 2.380

4.  Longitudinal Outcomes of Epicardial and Endocardial Pacemaker Leads in the Adult Fontan Patient.

Authors:  Geoffrey D Huntley; Abhishek J Deshmukh; Carole A Warnes; Suraj Kapa; Alexander C Egbe
Journal:  Pediatr Cardiol       Date:  2018-06-14       Impact factor: 1.655

5.  Transvenous Versus Epicardial Pacing in Fontan Patients.

Authors:  D E Segar; J R Maldonado; C G Brown; I H Law
Journal:  Pediatr Cardiol       Date:  2018-06-11       Impact factor: 1.655

6.  Epicardial versus endocardial permanent pacing in adults with congenital heart disease.

Authors:  Christopher John McLeod; Christine H Attenhofer Jost; Carole A Warnes; David Hodge; Linda Hyberger; Heidi M Connolly; Samuel J Asirvatham; Joseph A Dearani; David L Hayes; Naser M Ammash
Journal:  J Interv Card Electrophysiol       Date:  2010-06-19       Impact factor: 1.900

Review 7.  Neuroprostheses to treat neurogenic bladder dysfunction: current status and future perspectives.

Authors:  Nico J M Rijkhoff
Journal:  Childs Nerv Syst       Date:  2003-12-05       Impact factor: 1.475

8.  Surgical approaches to epicardial pacemaker placement: does pocket location affect lead survival?

Authors:  Brian J Lichtenstein; David P Bichell; Dana M Connolly; John J Lamberti; Suzanne M Shepard; Stephen P Seslar
Journal:  Pediatr Cardiol       Date:  2010-08-06       Impact factor: 1.655

9.  Permanent cardiac pacing in pediatric patients.

Authors:  Wael Lotfy; Ranya Hegazy; Osama AbdElAziz; Rodina Sobhy; Hossam Hasanein; Fawzan Shaltout
Journal:  Pediatr Cardiol       Date:  2012-08-12       Impact factor: 1.655

Review 10.  Pacing device therapy in infants and children: a review.

Authors:  Daiji Takeuchi; Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-10-27       Impact factor: 1.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.